Mapping the cancer-specific EORTC QLQ-C30 and EORTC QLQ-BR23 to the generic EQ-5D in metastatic breast cancer patients

E Kim, SK Ko, HY Kang - Quality of Life Research, 2012 - Springer
Purpose To develop a mapping algorithm for a conversion of the EORTC QLQ-C30 and
EORTC QLQ BR-23 into the EQ-5D-derived utilities in metastatic breast cancer (MBC) …

Mapping the Chinese version of the EORTC QLQ-BR53 onto the EQ-5D-5L and SF-6D utility scores

T Liu, S Li, M Wang, Q Sun, G Chen - The Patient-Patient-Centered …, 2020 - Springer
Objective This study aimed to develop mapping algorithms from the European Organization
for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-BR53 …

Mapping the EORTC QLQ-C30 onto the EQ-5D-3L: assessing the external validity of existing mapping algorithms

B Doble, P Lorgelly - Quality of Life Research, 2016 - Springer
Purpose To determine the external validity of existing mapping algorithms for predicting EQ-
5D-3L utility values from EORTC QLQ-C30 responses and to establish their generalizability …

Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients

SH Kim, MW Jo, HJ Kim, JH Ahn - Health and quality of life outcomes, 2012 - Springer
Abstract Background The European Organisation for Research and Treatment of Cancer
Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) is the instrument most frequently …

Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer

Y Hagiwara, T Shiroiwa, N Taira, T Kawahara… - Health and quality of life …, 2020 - Springer
Background To develop direct and indirect (response) mapping algorithms from the
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire …

An assessment of the external validity of mapping QLQ-C30 to EQ-5D preferences

R Crott, M Versteegh, C Uyl-de-Groot - Quality of Life Research, 2013 - Springer
Abstract Background Although cancer-specific Health-related Quality-of-Life measures are
commonly included in randomized clinical trials or other prospective non-randomized …

Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer

LA Gray, M Hernandez Alava, AJ Wailoo - BMC cancer, 2021 - Springer
Background The types of outcomes measured collected in clinical studies and those
required for cost-effectiveness analysis often differ. Decision makers routinely use quality …

Mapping the EORTC QLQ C‐30 onto the EQ‐5D instrument: the potential to estimate QALYs without generic preference data

L McKenzie, M Van Der Pol - Value in Health, 2009 - Wiley Online Library
Objectives: The aim of this article is to map the European Organization for Research and
Treatment of Cancer (EORTC) QLQ C‐30 onto the EQ‐5D measure to enable the estimation …

Validity and reliability of EQ-5D-3L for breast cancer patients in Korea

SH Kim, MW Jo, JW Lee, HJ Lee, JK Kim - Health and quality of life …, 2015 - Springer
Background Recently, breast cancer incidence and prevalence has been increasing.
Patients' health related quality of life is important considerations in the treatment of breast …

Mapping the QLQ-C30 quality of life cancer questionnaire to EQ-5D patient preferences

R Crott, A Briggs - The European journal of health economics, 2010 - Springer
Abstract Background Although cancer-specific Health-Related Quality of Life (HRQOL) are
commonly included in randomized clinical trials or other prospective non-randomized …